← Back to Clinical Trials
Recruiting NCT05868863

NCT05868863 Percutaneous Cementoplasty With or Without Screw Fixation

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05868863
Status Recruiting
Phase
Sponsor Centre Hospitalier Universitaire de Saint Etienne
Condition Interventional Radiology
Study Type OBSERVATIONAL
Enrollment 40 participants
Start Date 2019-11-01
Primary Completion 2027-06

Eligibility & Interventions

Sex All sexes
Min Age 80 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
datas of medical record.

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 40 participants in total. It began in 2019-11-01 with a primary completion date of 2027-06.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Bone pathologies such as fragility fractures and neoplastic bone lesions are frequently encountered in rheumatology. When these lesions affect the pelvis, they are responsible both for pain that is sometimes very disabling, but also for significant functional disorders due to their location. Different methods may be used to treat these lesions. The current challenge is to use less and less invasive techniques such as radio-guided cementoplasty to be able to treat all types of people, especially the most fragile. Among the elderly, the prevalence of these bone pathologies continues to increase due to the aging of the population and the improvement of diagnostic means.

Eligibility Criteria

Inclusion Criteria: * Patients with lesion of the bony pelvis treated by percutaneous cementoplasty with or without screw fixation at university hospital center of Saint-Etienne between January 1st 2012 and February 28th 2023 Exclusion Criteria: * Other interventional treatment at the same time and at the same location

Contact & Investigator

Central Contact

Sylvain GRANGE, MD

✉ grangesylvain@hotmail.fr

📞 (0)477127827

Principal Investigator

Sylvain GRANGE, MD

PRINCIPAL INVESTIGATOR

Centre Hospitalier Universitaire de Saint Etienne

Frequently Asked Questions

Who can join the NCT05868863 clinical trial?

This trial is open to participants of all sexes, aged 80 Years or older, studying Interventional Radiology. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05868863 currently recruiting?

Yes, NCT05868863 is actively recruiting participants. Contact the research team at grangesylvain@hotmail.fr for enrollment information.

Where is the NCT05868863 trial being conducted?

This trial is being conducted at Saint-Etienne, France.

Who is sponsoring the NCT05868863 clinical trial?

NCT05868863 is sponsored by Centre Hospitalier Universitaire de Saint Etienne. The principal investigator is Sylvain GRANGE, MD at Centre Hospitalier Universitaire de Saint Etienne. The trial plans to enroll 40 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology